Synopsis
0
CEP/COS
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
DOSAGE - TABLET;ORAL - EQ 100MG BASE
USFDA APPLICATION NUMBER - 203341
DOSAGE - TABLET;ORAL - EQ 400MG BASE
USFDA APPLICATION NUMBER - 203341
DOSAGE - TABLET;ORAL - EQ 500MG BASE
USFDA APPLICATION NUMBER - 203341
DOSAGE - CAPSULE;ORAL - EQ 100MG BASE
USFDA APPLICATION NUMBER - 217729
DOSAGE - CAPSULE;ORAL - EQ 50MG BASE
USFDA APPLICATION NUMBER - 217729
Related Excipient Companies
SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kirsch Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Dr. Paul Lohmann GmbH & Co. KGaA
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Aeon Procare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Corel Pharma Chem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DFE Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ideal Cures
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ingredion Pharma Solutions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Keval Exports
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Bold Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Neelkanth MineChem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nitika Pharmaceutical Specialities
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Novo Excipients
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pharmatrans-Sanaq
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Prachin Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Shenmei Pharmaceutical Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Sigachi Industries
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Fillers, Diluents & Binders
Coating Systems & Additives
Disintegrants & Superdisintegrants
Lubricants & Glidants
Thickeners and Stabilizers
Direct Compression
Controlled & Modified Release
Co-Processed Excipients
Granulation
Film Formers & Plasticizers
Topical
Emulsifying Agents
Chewable & Orodispersible Aids
Parenteral
Taste Masking
Rheology Modifiers
Surfactant & Foaming Agents
API Stability Enhancers
Solubilizers
Digital Content
NEWS #PharmaBuzz
Global Sales Information
Market Place
ABOUT THIS PAGE
36
PharmaCompass offers a list of Bosutinib Monohydrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Bosutinib Monohydrate manufacturer or Bosutinib Monohydrate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Bosutinib Monohydrate manufacturer or Bosutinib Monohydrate supplier.
PharmaCompass also assists you with knowing the Bosutinib Monohydrate API Price utilized in the formulation of products. Bosutinib Monohydrate API Price is not always fixed or binding as the Bosutinib Monohydrate Price is obtained through a variety of data sources. The Bosutinib Monohydrate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A BOSULIF manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of BOSULIF, including repackagers and relabelers. The FDA regulates BOSULIF manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. BOSULIF API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of BOSULIF manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A BOSULIF supplier is an individual or a company that provides BOSULIF active pharmaceutical ingredient (API) or BOSULIF finished formulations upon request. The BOSULIF suppliers may include BOSULIF API manufacturers, exporters, distributors and traders.
click here to find a list of BOSULIF suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A BOSULIF DMF (Drug Master File) is a document detailing the whole manufacturing process of BOSULIF active pharmaceutical ingredient (API) in detail. Different forms of BOSULIF DMFs exist exist since differing nations have different regulations, such as BOSULIF USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A BOSULIF DMF submitted to regulatory agencies in the US is known as a USDMF. BOSULIF USDMF includes data on BOSULIF's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The BOSULIF USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of BOSULIF suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The BOSULIF Drug Master File in Japan (BOSULIF JDMF) empowers BOSULIF API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the BOSULIF JDMF during the approval evaluation for pharmaceutical products. At the time of BOSULIF JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of BOSULIF suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a BOSULIF Drug Master File in Korea (BOSULIF KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of BOSULIF. The MFDS reviews the BOSULIF KDMF as part of the drug registration process and uses the information provided in the BOSULIF KDMF to evaluate the safety and efficacy of the drug.
After submitting a BOSULIF KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their BOSULIF API can apply through the Korea Drug Master File (KDMF).
click here to find a list of BOSULIF suppliers with KDMF on PharmaCompass.
A BOSULIF written confirmation (BOSULIF WC) is an official document issued by a regulatory agency to a BOSULIF manufacturer, verifying that the manufacturing facility of a BOSULIF active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting BOSULIF APIs or BOSULIF finished pharmaceutical products to another nation, regulatory agencies frequently require a BOSULIF WC (written confirmation) as part of the regulatory process.
click here to find a list of BOSULIF suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing BOSULIF as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for BOSULIF API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture BOSULIF as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain BOSULIF and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a BOSULIF NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of BOSULIF suppliers with NDC on PharmaCompass.
BOSULIF Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of BOSULIF GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right BOSULIF GMP manufacturer or BOSULIF GMP API supplier for your needs.
A BOSULIF CoA (Certificate of Analysis) is a formal document that attests to BOSULIF's compliance with BOSULIF specifications and serves as a tool for batch-level quality control.
BOSULIF CoA mostly includes findings from lab analyses of a specific batch. For each BOSULIF CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
BOSULIF may be tested according to a variety of international standards, such as European Pharmacopoeia (BOSULIF EP), BOSULIF JP (Japanese Pharmacopeia) and the US Pharmacopoeia (BOSULIF USP).
